AMACR / p504s Antibody (Immunohistochemistry)

The AMACR (Alpha-Methylacyl-CoA Racemase) antibody, also known as p504s,
is a highly specific and sensitive IHC marker. It helps identify prostatic adenocarcinoma
and clearly differentiates malignant lesions from benign prostate tissues.
In addition, AMACR is a 42 kDa peroxisomal and mitochondrial enzyme involved in the β-oxidation of branched-chain fatty acids.

Moreover, AMACR is strongly overexpressed in prostate cancer cells compared with benign glands.
As a result, it serves as an excellent positive diagnostic marker in routine immunohistochemistry.
Therefore, when used together with basal cell markers such as p63 or 34βE12,
AMACR significantly increases diagnostic accuracy in prostate cancer evaluation.

🔬 Features and Benefits

• Highly specific marker for prostatic adenocarcinoma
• Clear brown cytoplasmic staining in positive cells
• Provides higher diagnostic accuracy when paired with p63 or 34βE12
• Useful for renal and hepatic carcinoma evaluation
• Stable for up to 18 months at 2–8 °C

💡 Diagnostic Applications

• Detection of prostatic adenocarcinoma
• Differentiation between benign and malignant prostate lesions
• Assessment of renal and hepatic carcinomas
• Research on fatty acid metabolism and enzymatic pathways

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co., the exclusive representative of
Talent Biomedical in Iran, supplies premium-quality IHC antibodies, including AMACR / p504s.
Furthermore, the company emphasizes diagnostic precision, international quality standards, and strong technical support.
As a result, pathology and molecular laboratories across Iran benefit from reliable and consistent diagnostic solutions.

“Download Brochure”